Cargando…
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we focused on the infiltration and programmed death ligand 1 (PD-L1) expression of tumor-associated macrophages (TAMs) in the tumor microen...
Autores principales: | Park, Dong-Jun, Sung, Pil-Soo, Lee, Gil-Won, Cho, Sung-Woo, Kim, Sung-Min, Kang, Byung-Yoon, Hur, Won-Hee, Yang, Hyun, Lee, Soon-Kyu, Lee, Sung-Hak, Jung, Eun-Sun, Seo, Chang-Ho, Ahn, Joseph, Choi, Ho-Joong, You, Young-Kyoung, Jang, Jeong-Won, Bae, Si-Hyun, Choi, Jong-Young, Yoon, Seung-Kew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124544/ https://www.ncbi.nlm.nih.gov/pubmed/33946835 http://dx.doi.org/10.3390/ijms22094710 |
Ejemplares similares
-
Intrahepatic inflammatory IgA(+)PD-L1(high) monocytes in hepatocellular carcinoma development and immunotherapy
por: Sung, Pil Soo, et al.
Publicado: (2022) -
Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma
por: Sung, Pil Soo, et al.
Publicado: (2020) -
Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
por: Lee, Soon Kyu, et al.
Publicado: (2021) -
Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2020) -
Patient-Derived Avatar Mouse Model to Predict the Liver Immune Homeostasis of Long-Term Stable Liver Transplant Patients
por: Lee, Soon Kyu, et al.
Publicado: (2022)